THIRD AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT RENEWALExclusive License Agreement Renewal • April 14th, 2022 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
THIS AMENDMENT TO THE EXCLUSIVE LICENSE AGREMEMENT RENEWAL (this “Amendment”) is made and entered into as of January 27, 2021, by and among Skinvisible, Inc., a Nevada corporation (referred to as “SKINVISIBLE” ), and Quoin Pharmaceuticals, Inc., a Delaware corporation (“Licensee”).
SECOND AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT RENEWAL by and among SKINVISIBLE, INC., QUOIN PHARMACEUTICALS, INC., Dated as of May 8, 2020Exclusive License Agreement Renewal • April 14th, 2022 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
THIS AMENDMENT TO THE EXCLUSIVE LICENSE AGREMEMENT RENEWAL (this “Amendment”) is made and entered into as of September 30, 2020, by and among Skinvisible, Inc., a Nevada corporation (referred to as “SKINVISIBLE” ), and Quoin Pharmaceuticals, Inc., a Delaware corporation (“Licensee”).
